NASDAQ Morning Movers; (CLDX), (MERU), (INPH), (INFI)
Category: Investment, Trading
Visit: Celldex Therapeutics Inc.
Point Roberts, WA - December 10, 2012 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors reports on the top percentage gainers on the NASDAQ for December 10th, 2012.
Celldex Therapeutics Inc. (NASDAQ:CLDX) is trading at $6.821 and gaining $1.30 or 23.57% on a total volume of 7,758,960 shares, CLDX is today’s top morning mover.
Shares in CLDX rose after the company reported positive clinical trial results for an experimental treatment for breast cancer. Celldex said patients who were treated with CDX-011 had higher response rates than patients who received other treatments chosen by investigators as well as also appearing to live longer. With the release of this news stocks in CLDX rose to an all year high of $7.14.
Meru Networks Inc. (NASDAQ:MERU), trading at $2.58 gained $0.33 or 14.67% on a volume of 122,745 shares.
Interphase Corp. (NASDAQ:INPH), trading at $2.91 rose $0.37 or 14.57% on a volume of 43,147 shares.
Infinity Pharmaceuticals Inc. (NASDAQ:INFI), trading at $25.79 moved $3.27 or 14.50% on a volume of 605,265 shares.
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
Become an Investorideas.com Member and access our 13 online stock directories 24/7 - water, renewable energy, mining stocks and more…
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com